SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002336
Filing Date
2022-08-12
Accepted
2022-08-12 06:18:37
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20220630x10q.htm   iXBRL 10-Q 1405131
2 EX-31.1 kprx-20220630xex31d1.htm EX-31.1 9832
3 EX-32.1 kprx-20220630xex32d1.htm EX-32.1 6076
  Complete submission text file 0001410578-22-002336.txt   5765287

Data Files

Seq Description Document Type Size
4 EX-101.SCH kprx-20220630.xsd EX-101.SCH 48312
5 EX-101.CAL kprx-20220630_cal.xml EX-101.CAL 44646
6 EX-101.DEF kprx-20220630_def.xml EX-101.DEF 179491
7 EX-101.LAB kprx-20220630_lab.xml EX-101.LAB 415375
8 EX-101.PRE kprx-20220630_pre.xml EX-101.PRE 305437
59 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20220630x10q_htm.xml XML 913769
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 221157716
SIC: 2834 Pharmaceutical Preparations